284 related articles for article (PubMed ID: 12205421)
21. Recombinant human bone morphogenetic protein-2 overcomes the inhibitory effect of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), on posterolateral lumbar intertransverse process spine fusion.
Martin GJ; Boden SD; Titus L
Spine (Phila Pa 1976); 1999 Nov; 24(21):2188-93; discussion 2193-4. PubMed ID: 10562982
[TBL] [Abstract][Full Text] [Related]
22. Experimental spinal fusion with recombinant human bone morphogenetic protein-2 delivered by a synthetic polymer and beta-tricalcium phosphate in a rabbit model.
Namikawa T; Terai H; Suzuki E; Hoshino M; Toyoda H; Nakamura H; Miyamoto S; Takahashi N; Ninomiya T; Takaoka K
Spine (Phila Pa 1976); 2005 Aug; 30(15):1717-22. PubMed ID: 16094272
[TBL] [Abstract][Full Text] [Related]
23. New formulations of demineralized bone matrix as a more effective graft alternative in experimental posterolateral lumbar spine arthrodesis.
Martin GJ; Boden SD; Titus L; Scarborough NL
Spine (Phila Pa 1976); 1999 Apr; 24(7):637-45. PubMed ID: 10209791
[TBL] [Abstract][Full Text] [Related]
24. Experimental posterolateral lumbar spinal fusion with a demineralized bone matrix gel.
Morone MA; Boden SD
Spine (Phila Pa 1976); 1998 Jan; 23(2):159-67. PubMed ID: 9474720
[TBL] [Abstract][Full Text] [Related]
25. The use of coralline hydroxyapatite with bone marrow, autogenous bone graft, or osteoinductive bone protein extract for posterolateral lumbar spine fusion.
Boden SD; Martin GJ; Morone M; Ugbo JL; Titus L; Hutton WC
Spine (Phila Pa 1976); 1999 Feb; 24(4):320-7. PubMed ID: 10065514
[TBL] [Abstract][Full Text] [Related]
26. The effect of osteogenic protein-1 in instrumented and noninstrumented posterolateral fusion in rabbits.
Jenis LG; Wheeler D; Parazin SJ; Connolly RJ
Spine J; 2002; 2(3):173-8. PubMed ID: 14589490
[TBL] [Abstract][Full Text] [Related]
27. Posterolateral intertransverse process spinal arthrodesis with rhBMP-2 in a nonhuman primate: important lessons learned regarding dose, carrier, and safety.
Martin GJ; Boden SD; Marone MA; Marone MA; Moskovitz PA
J Spinal Disord; 1999 Jun; 12(3):179-86. PubMed ID: 10382769
[TBL] [Abstract][Full Text] [Related]
28. Quantitative study of parathyroid hormone (1-34) and bone morphogenetic protein-2 on spinal fusion outcomes in a rabbit model of lumbar dorsolateral intertransverse process arthrodesis.
Lina IA; Puvanesarajah V; Liauw JA; Lo SF; Santiago-Dieppa DR; Hwang L; Mao A; Bydon A; Wolinsky JP; Sciubba DM; Gokaslan Z; Holmes C; Witham TF
Spine (Phila Pa 1976); 2014 Mar; 39(5):347-55. PubMed ID: 24365898
[TBL] [Abstract][Full Text] [Related]
29. Radiographic, biomechanical, and histological evaluation of rhBMP-2 in a 3-level intertransverse process spine fusion: an ovine study.
Toth JM; Wang M; Lawson J; Badura JM; DuBose KB
J Neurosurg Spine; 2016 Dec; 25(6):733-739. PubMed ID: 27367941
[TBL] [Abstract][Full Text] [Related]
30. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
[TBL] [Abstract][Full Text] [Related]
31. Influence of 45S5 Bioactive Glass in A Standard Calcium Phosphate Collagen Bone Graft Substitute on the Posterolateral Fusion of Rabbit Spine.
Pugely AJ; Petersen EB; DeVries-Watson N; Fredericks DC
Iowa Orthop J; 2017; 37():193-198. PubMed ID: 28852357
[TBL] [Abstract][Full Text] [Related]
32. Instrumented anterior lumbar interbody fusion with equine bone protein extract.
Li H; Zou X; Springer M; Briest A; Lind M; Bünger C
Spine (Phila Pa 1976); 2007 Feb; 32(4):E126-9. PubMed ID: 17304121
[TBL] [Abstract][Full Text] [Related]
33. The effects of BMP-7 in a rat posterolateral intertransverse process fusion model.
Salamon ML; Althausen PL; Gupta MC; Laubach J
J Spinal Disord Tech; 2003 Feb; 16(1):90-5. PubMed ID: 12571490
[TBL] [Abstract][Full Text] [Related]
34. A pilot safety and efficacy study of OP-1 putty (rhBMP-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions.
Vaccaro AR; Patel T; Fischgrund J; Anderson DG; Truumees E; Herkowitz H; Phillips F; Hilibrand A; Albert TJ
Eur Spine J; 2003 Oct; 12(5):495-500. PubMed ID: 12908103
[TBL] [Abstract][Full Text] [Related]
35. Reversing the inhibitory effect of nicotine on spinal fusion using an osteoinductive protein extract.
Silcox DH; Boden SD; Schimandle JH; Johnson P; Whitesides TE; Hutton WC
Spine (Phila Pa 1976); 1998 Feb; 23(3):291-6; discussion 297. PubMed ID: 9507615
[TBL] [Abstract][Full Text] [Related]
36. A prospective randomized study of posterolateral lumbar fusion using osteogenic protein-1 (OP-1) versus local autograft with ceramic bone substitute: emphasis of surgical exploration and histologic assessment.
Kanayama M; Hashimoto T; Shigenobu K; Yamane S; Bauer TW; Togawa D
Spine (Phila Pa 1976); 2006 May; 31(10):1067-74. PubMed ID: 16648739
[TBL] [Abstract][Full Text] [Related]
37. 2000 Young Investigator Research Award winner. Evaluation of OP-1 as a graft substitute for intertransverse process lumbar fusion.
Grauer JN; Patel TC; Erulkar JS; Troiano NW; Panjabi MM; Friedlaender GE
Spine (Phila Pa 1976); 2001 Jan; 26(2):127-33. PubMed ID: 11154530
[TBL] [Abstract][Full Text] [Related]
38. The Effects of High-Dose Parathyroid Hormone Treatment on Fusion Outcomes in a Rabbit Model of Posterolateral Lumbar Spinal Fusion Alone and in Combination with Bone Morphogenetic Protein 2 Treatment.
Holmes CA; Ishida W; Elder BD; Lo SL; Chen YA; Kim E; Locke J; Taylor M; Witham TF
World Neurosurg; 2018 Jul; 115():e366-e374. PubMed ID: 29678698
[TBL] [Abstract][Full Text] [Related]
39. Experimental spinal fusion with use of recombinant human bone morphogenetic protein 2.
Itoh H; Ebara S; Kamimura M; Tateiwa Y; Kinoshita T; Yuzawa Y; Takaoka K
Spine (Phila Pa 1976); 1999 Jul; 24(14):1402-5. PubMed ID: 10423783
[TBL] [Abstract][Full Text] [Related]
40. The use of recombinant human bone morphogenetic protein 2 (rhBMP-2) to promote spinal fusion in a nonhuman primate anterior interbody fusion model.
Hecht BP; Fischgrund JS; Herkowitz HN; Penman L; Toth JM; Shirkhoda A
Spine (Phila Pa 1976); 1999 Apr; 24(7):629-36. PubMed ID: 10209790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
